Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis-Reference-Cited by-同舟云学术

Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis

Published:2023-11 Issue:6 Volume:22 Page:858-871
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Lin Long-Wang,Yan Le-Ye,Ke Kun,Yang Wei-Zhu,Lin Jun-Qing^ORCID,Huang Ning

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference61 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus;Zhang;Int J Surg,2015

3. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west;Lu;Lancet Gastroenterol Hepatol,2019

4. Natural history of untreated nonsurgical hepatocellular carcinoma;Yeung;Am J Gastroenterol,2005

5. The progress in the treatment of hepatocellular carcinoma with portal vein tumor thrombus;Luo;Front Oncol,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using a Monte Carlo simulation to analyze the ideal activity for a phosphorus-32 polymeric brachytherapy source for paraspinal tumors;Radiation Physics and Chemistry;2024-11

2. Application of radioactive iodine-125 microparticles in hepatocellular carcinoma with portal vein embolus;World Journal of Gastrointestinal Surgery;2024-07-27

3. Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis;Discover Oncology;2024-05-14